132 related articles for article (PubMed ID: 28189244)
1. Acid-sensitive dextran prodrug: A higher molecular weight makes a better efficacy.
Li D; Han J; Ding J; Chen L; Chen X
Carbohydr Polym; 2017 Apr; 161():33-41. PubMed ID: 28189244
[TBL] [Abstract][Full Text] [Related]
2. Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy.
Jin R; Guo X; Dong L; Xie E; Cao A
Colloids Surf B Biointerfaces; 2017 Oct; 158():47-56. PubMed ID: 28667893
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
Du YZ; Weng Q; Yuan H; Hu FQ
ACS Nano; 2010 Nov; 4(11):6894-902. PubMed ID: 20939508
[TBL] [Abstract][Full Text] [Related]
4. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
[TBL] [Abstract][Full Text] [Related]
5. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
[TBL] [Abstract][Full Text] [Related]
6. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
7. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic.
Xu W; Ding J; Xiao C; Li L; Zhuang X; Chen X
Biomaterials; 2015 Jun; 54():72-86. PubMed ID: 25907041
[TBL] [Abstract][Full Text] [Related]
8. Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.
Situ JQ; Ye YQ; Zhu XL; Yu RS; You J; Yuan H; Hu FQ; Du YZ
Int J Nanomedicine; 2015; 10():665-75. PubMed ID: 25653517
[TBL] [Abstract][Full Text] [Related]
9. A bottlebrush-architectured dextran polyprodrug as an acidity-responsive vector for enhanced chemotherapy efficiency.
Zhang T; Wang Y; Ma X; Hou C; Lv S; Jia D; Lu Y; Xue P; Kang Y; Xu Z
Biomater Sci; 2020 Jan; 8(1):473-484. PubMed ID: 31755481
[TBL] [Abstract][Full Text] [Related]
10. Sialic-Acid-Anchored Micelles: A Hierarchical Targeting Device for Enhanced Tumor Tissue Accumulation and Cellular Internalization.
Zhu ML; Xu XL; Wang XJ; Zhang NN; Lu KJ; Qi J; Jin FY; Liu D; Du YZ
Mol Pharm; 2018 Sep; 15(9):4235-4246. PubMed ID: 30110551
[TBL] [Abstract][Full Text] [Related]
11. Preparation of pH-Sensitive Dextran Nanoparticle for Doxorubicin Delivery.
Wang B; Liu P; Shi B; Gao J; Gong P
J Nanosci Nanotechnol; 2015 Apr; 15(4):2613-8. PubMed ID: 26353472
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled and pH-sensitive mixed micelles as an intracellular doxorubicin delivery system.
Jafarzadeh-Holagh S; Hashemi-Najafabadi S; Shaki H; Vasheghani-Farahani E
J Colloid Interface Sci; 2018 Aug; 523():179-190. PubMed ID: 29621645
[TBL] [Abstract][Full Text] [Related]
13. Dual responsive dextran-graft-poly (N-isopropylacrylamide)/doxorubicin prodrug via Schiff base reaction.
Carneiro MJM; Paula CBA; Ribeiro IS; de Lima LRM; Ribeiro FOS; Silva DA; Araújo GS; Marinho Filho JDB; Araújo AJ; Freire RS; Feitosa JPA; de Paula RCM
Int J Biol Macromol; 2021 Aug; 185():390-402. PubMed ID: 34153357
[TBL] [Abstract][Full Text] [Related]
14. Dextran-doxorubicin prodrug nanoparticles conjugated with CD147 monoclonal antibody for targeted drug delivery in hepatoma therapy.
Tian H; Yu L; Zhang M; He J; Sun X; Ni P
Colloids Surf B Biointerfaces; 2023 Aug; 228():113400. PubMed ID: 37331192
[TBL] [Abstract][Full Text] [Related]
15. Schiff base bond-linked polysaccharide-doxorubicin conjugate for upregulated cancer therapy.
Feng X; Li D; Han J; Zhuang X; Ding J
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1121-1128. PubMed ID: 28482476
[TBL] [Abstract][Full Text] [Related]
16. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
17. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
Huang X; Liao W; Xie Z; Chen D; Zhang CY
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
[TBL] [Abstract][Full Text] [Related]
18. Hemocompatible curcumin-dextran micelles as pH sensitive pro-drugs for enhanced therapeutic efficacy in cancer cells.
Raveendran R; Bhuvaneshwar GS; Sharma CP
Carbohydr Polym; 2016 Feb; 137():497-507. PubMed ID: 26686156
[TBL] [Abstract][Full Text] [Related]
19. Intracellular pH-sensitive PEG-block-acetalated-dextrans as efficient drug delivery platforms.
Zhang Z; Chen X; Chen L; Yu S; Cao Y; He C; Chen X
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10760-6. PubMed ID: 24090231
[TBL] [Abstract][Full Text] [Related]
20. Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma.
Li D; Xu W; Li P; Ding J; Cheng Z; Chen L; Yan L; Chen X
Mol Pharm; 2016 Dec; 13(12):4231-4235. PubMed ID: 27784155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
